Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (644)	5/11/1998 12:37:00 AM
From: Wisee	Respond to of 1185

Edward, Great comments. Wisee

To: Edward W. Richmond who wrote (644)	5/11/1998 9:25:00 AM
From: SOROS	Read Replies (2) \| Respond to of 1185

I think we will see cooler heads with some patience come in today that KNOW the value of Hoffmann-LaRoche and this deal. Most of the hotheads looking for quick scores are gone now. Those that want to own a stock for 2-5 years and watch their money go up TEN times in value will take over. I, for one, will be quite happy to double my money each year on average -- sure beats mutual funds -- and sure beats the heartburn associated with jumping from one "hot lead" to another. I remain, SOROS ps I think fair value for NRT RIGHT NOW is $4.00, and we should see it head that way. Should stabilize near $5-6 this year based on what we now know. If other announcements and DEALS are cut, WATCH OUT!